Rating History for Protalix BioTherapeutics (PLX) by UBS

More Stocks Rated by UBS | Latest Ratings for PLX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
2/8/2011 N/A Downgrade Neutral
(N/A)		 N/A
(N/A)		 10.15
(2.35)		 -76.85% Details